Bremelanotide improved sexual desire in women with HSDD
New England Journal of Medicine
2019
Study summary
Bremelanotide was tested in women with hypoactive sexual desire disorder.
Key findings
Treatment improved sexual desire scores compared with placebo.
Study details
Study type
randomized clinical trial
Journal
New England Journal of Medicine
DOI / PubMed
10.1056/NEJMoa1813163
Year
2019
Explore peptide profiles
Discover compounds, understand their mechanisms, and explore the research behind each peptide.
